|
Nov 6
|
BioNTech cuts 2023 revenue target on reduced prospects for vaccine
|
|
Nov 6
|
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
|
|
Nov 6
|
BioNTech cuts annual revenue guidance amid slipping COVID-19 jab demand
|
|
Sep 7
|
Moderna (MRNA) Updated COVID Jab Effective Against Pirola Variant
|
|
Sep 5
|
Novavax (NVAX) Stock Increases 9% in a Month: Here's Why
|
|
Sep 5
|
UPDATE 2-UK regulator approves updated Pfizer-BioNTech COVID vaccine
|
|
Aug 10
|
BioNTech SE (NASDAQ:BNTX) Q2 2023 Earnings Call Transcript
|
|
Aug 8
|
15 Worst Performing Biotech Stocks in 2023
|
|
Aug 8
|
Q2 2023 BioNTech SE Earnings Call
|
|
Aug 7
|
BioNTech Stock Was a Covid Darling. Now It’s Paying the Price.
|
|
Aug 7
|
BioNTech Se (BNTX) Q2 2023 Earnings Call Transcript
|
|
Aug 7
|
BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations
|
|
Aug 7
|
Why BioNTech Stock Was Sinking Today
|
|
Aug 7
|
BioNTech Revenue Plunges on Falling Demand for COVID-19 Vaccines
|
|
Aug 7
|
PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
|
|
Aug 7
|
Trending tickers: Saudi Aramco | PageGroup | LSL Property Service | BioNTech
|
|
Aug 7
|
UPDATE 1-BioNTech reduces drug development spend as COVID vaccine sales plunge
|
|
Aug 7
|
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
|
|
Aug 7
|
BioNTech reduces drug development spend as COVID shot sales plunge
|
|
Jul 3
|
Moderna (MRNA) Submits Filing in EU for Updated COVID-19 Jab
|